BIOLASE
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BIOLASE's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1% to $49,164,000. The net income raised on -$20,632,000 and profit margin reached -42%. Total operating expenses were $34,661,000.

Profit Margin

BIOLASE, Inc. (NASDAQ:BIOL): Profit margin
2014 47.65M -18.92M -39.71%
2015 48.47M -20.27M -41.83%
2016 51.81M -15.37M -29.67%
2017 46.92M -16.85M -35.91%
2018 46.15M -21.51M -46.62%
2019 37.79M -17.85M -47.24%
2020 22.78M -16.82M -73.88%
2021 39.18M -16.15M -41.23%
2022 48.46M -28.63M -59.09%
2023 49.16M -20.63M -41.97%

BIOL Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
49.16M48.46M39.18M22.78M37.79M46.15M46.92M51.81M48.47M47.65M
Cost of revenue
32.43M32.55M22.65M16.60M23.51M29.26M31.8M31.50M32.52M29.48M
Gross profit
16.72M15.91M16.52M6.17M14.28M16.89M15.12M20.30M15.95M18.17M
Operating exp.
Research and development
6.00M7.26M6.04M3.69M4.76M5.20M6.22M7.79M7.28M4.57M
Selling and marketing
18.44M21.67M15.33M11.24M14.39M18.12M16.71M17.01M18.69M16.37M
Total operating expenses
34.66M41.24M32.64M24.70M29.90M35.09M32.65M35.27M36.59M36.11M
Operating income
-17.93M-25.33M-16.11M-18.53M-15.62M-20.88M-18.03M-14.96M-19.91M-17.94M
Other income (expenses), net
-2.66M-3.18M23K1.83M-2.27M-2.74M605K-332K-185K-873K
Income before tax
-20.60M-28.52M-16.09M-16.70M-17.89M-21.45M-17.43M-15.22M-20.1M-18.81M
Income tax expense
31K109K65K128K-44K63K-582K151K178K112K
Net income
-20.63M-28.63M-16.15M-16.82M-17.85M-21.51M-16.85M-15.37M-20.27M-18.92M
Earnings per share
Basic EPS
-16.14-413.19-273.41-688.19-1.92K-2.61K-2.85K-3.16K-4.35K-5.25K
Diluted EPS
-16.14-413.19-273.41-688.19-1.92K-2.61K-2.85K-3.16K-4.35K-5.25K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source